PMID- 34281115 OWN - NLM STAT- MEDLINE DCOM- 20210802 LR - 20210802 IS - 1660-4601 (Electronic) IS - 1661-7827 (Print) IS - 1660-4601 (Linking) VI - 18 IP - 13 DP - 2021 Jul 5 TI - Utilization of Subcutaneous Cardioverter-Defibrillator in Poland and Europe-Comparison of the Results of Multi-Center Registries. LID - 10.3390/ijerph18137178 [doi] LID - 7178 AB - The implantation of a subcutaneous cardioverter-defibrillator (S-ICD) may be used instead of a traditional transvenous system to prevent sudden cardiac death. Our aim was to compare the characteristics of S-ICD patients from the multi-center registry of S-ICD implantations in Poland with the published results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI). We compared data of 137 Polish S-ICD patients with 68 patients from the ESSS-SICDI registry. The groups did not differ significantly in terms of sex, prevalence of ischemic cardiomyopathy, concomitant diseases, and the rate of primary prevention indication. Polish patients had more advanced heart failure (New York Heart Association (NYHA) class III: 11.7% vs. 2.9%, NYHA II: 48.9% vs. 29.4%, NYHA I: 39.4% vs. 67.7%, p < 0.05 each). Young age (75.9% vs. 50%, p < 0.05) and no vascular access (7.3% vs. 0%, p < 0.05) were more often indications for S-ICD. The percentage of patients after transvenous system removal due to infections was significantly higher in the Polish group (11% vs. 1.5%, p < 0.05). In the European population, S-ICD was more frequently chosen because of patients' active lifestyle and patients' preference (both 10.3% vs. 0%, p < 0.05). Our analysis shows that in Poland, compared to other European countries, subcutaneous cardioverters-defibrillators are being implanted in patients at a more advanced stage of chronic heart failure. The most frequent reason for choosing a subcutaneous system instead of a transvenous ICD is the young age of a patient. FAU - Kempa, Maciej AU - Kempa M AUID- ORCID: 0000-0002-3472-2883 AD - Department of Cardiology and Electrotherapy, Medical University of Gdansk, 80-210 Gdansk, Poland. FAU - Przybylski, Andrzej AU - Przybylski A AD - Medical College, University of Rzeszow, 35-959 Rzeszow, Poland. AD - Cardiology Department with the Acute Coronary Syndromes Subdivision, Clinical Provincial Hospital No. 2, 35-301 Rzeszow, Poland. FAU - Budrejko, Szymon AU - Budrejko S AUID- ORCID: 0000-0002-5254-0813 AD - Department of Cardiology and Electrotherapy, Medical University of Gdansk, 80-210 Gdansk, Poland. FAU - Fabiszak, Tomasz AU - Fabiszak T AD - Department of Cardiology and Internal Diseases, Collegium Medicum, Nicolaus Copernicus University, 85-094 Bydgoszcz, Poland. FAU - Lewandowski, Michal AU - Lewandowski M AD - 2nd Department of Arrhythmia, National Institute of Cardiology, 04-628 Warsaw, Poland. FAU - Kaczmarek, Krzysztof AU - Kaczmarek K AD - Department of Electrocardiology, Medical University of Lodz, 90-647 Lodz, Poland. FAU - Tajstra, Mateusz AU - Tajstra M AD - 3rd Department of Cardiology, Silesian Centre for Heart Diseases, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland. FAU - Grabowski, Marcin AU - Grabowski M AUID- ORCID: 0000-0003-3306-0301 AD - 1st Chair and Department of Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland. FAU - Mitkowski, Przemyslaw AU - Mitkowski P AD - 1st Department of Cardiology, Chair of Cardiology, Karol Marcinkowski University of Medical Sciences, 61-701 Poznan, Poland. FAU - Tubek, Stanislaw AU - Tubek S AUID- ORCID: 0000-0002-0059-5150 AD - Department of Heart Diseases, Wroclaw Medical University, 50-367 Wroclaw, Poland. FAU - Jedrzejczyk-Patej, Ewa AU - Jedrzejczyk-Patej E AUID- ORCID: 0000-0002-1009-0076 AD - Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Medical University of Silesia Silesian Centre for Heart Diseases, 41-800 Zabrze, Poland. FAU - Lenarczyk, Radoslaw AU - Lenarczyk R AUID- ORCID: 0000-0002-4680-6734 AD - Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Medical University of Silesia Silesian Centre for Heart Diseases, 41-800 Zabrze, Poland. FAU - Jagielski, Dariusz AU - Jagielski D AD - Department of Cardiology, Centre for Heart Diseases, 4th Military Hospital, 50-981 Wroclaw, Poland. FAU - Romanek, Janusz AU - Romanek J AD - Medical College, University of Rzeszow, 35-959 Rzeszow, Poland. AD - Cardiology Department with the Acute Coronary Syndromes Subdivision, Clinical Provincial Hospital No. 2, 35-301 Rzeszow, Poland. FAU - Rydlewska, Anna AU - Rydlewska A AD - Institute of Cardiology, Faculty of Medicine, Jagiellonian University Medical College, 31-008 Krakow, Poland. AD - Department of Electrocardiology, The John Paul II Hospital, 31-202 Krakow, Poland. FAU - Orski, Zbigniew AU - Orski Z AD - Department of Cardiology and Internal Diseases, Military Institute of Medicine, 04-141 Warsaw, Poland. FAU - Zakrzewska-Koperska, Joanna AU - Zakrzewska-Koperska J AD - 1st Department of Arrhythmia, National Institute of Cardiology, 04-628 Warsaw, Poland. FAU - Filipecki, Artur AU - Filipecki A AD - 1st Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, 40-055 Katowice, Poland. FAU - Janowski, Marcin AU - Janowski M AUID- ORCID: 0000-0002-9574-5093 AD - Chair and Department of Cardiology, Medical University of Lublin, 20-059 Lublin, Poland. FAU - Potpara, Tatjana AU - Potpara T AUID- ORCID: 0000-0001-6285-6902 AD - School of Medicine, Belgrade University, 11000 Belgrade, Serbia. FAU - Boveda, Serge AU - Boveda S AUID- ORCID: 0000-0002-1280-7042 AD - Cardiology, Cardiac Arrhythmias Management Department, Clinique Pasteur, 31076 Toulouse, France. LA - eng PT - Journal Article DEP - 20210705 PL - Switzerland TA - Int J Environ Res Public Health JT - International journal of environmental research and public health JID - 101238455 SB - IM MH - *Defibrillators, Implantable MH - Europe MH - Humans MH - New York MH - Poland/epidemiology MH - Registries MH - Treatment Outcome PMC - PMC8297309 OTO - NOTNLM OT - implantable cardioverter-defibrillator OT - subcutaneous implantable cardioverter-defibrillator OT - sudden cardiac death OT - ventricular arrhythmia COIS- Maciej Kempa-received consultant fees or advisory board membership fees from: Abbott, Biotronik, Boston Scientific, Medtronic; Michal Lewandowski-lecture honoraria, travel expenses coverage from Boston Scientific and lecture honoraria from Abbott; Krzysztof Kaczmarek-proctoring fees from Boston Scientific; Marcin Grabowski-received consultant and lectures fees from Medtronic, Biotronik, Abbott and Boston Scientific; Przemyslaw Mitkowski-received consultant fees or research grants or advisory board membership fees from: Abbott, Biotronik, Boston Scientific, Medtronic; Stanislaw Tubek-received a consultancy fee from Boston Scientific; Ewa Jedrzejczyk-Patej-received consultant fees from Medtronic, Biotronik, Abbott and Boston Scientific; Radoslaw Lenarczyk-received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement no 847999; Dariusz Jagielski-received a honorarium from Boston Scientific for a lecture during a webinar; Anna Rydlewska-consultant for Medtronic's Warsaw Education Center; Serge Boveda-consultant for Medtronic, Boston Scietific, Microport and Zoll; Andrzej Przybylski, Szymon Budrejko, Tomasz Fabiszak, Mateusz Tajstra, Janusz Romanek, Zbigniew Orski, Joanna Zakrzewska-Koperska, Artur Filipecki, Marcin Janowski and Tatjana Potpara declared no conflict of interest. EDAT- 2021/07/21 06:00 MHDA- 2021/08/03 06:00 PMCR- 2021/07/05 CRDT- 2021/07/20 01:02 PHST- 2021/04/28 00:00 [received] PHST- 2021/06/01 00:00 [revised] PHST- 2021/06/29 00:00 [accepted] PHST- 2021/07/20 01:02 [entrez] PHST- 2021/07/21 06:00 [pubmed] PHST- 2021/08/03 06:00 [medline] PHST- 2021/07/05 00:00 [pmc-release] AID - ijerph18137178 [pii] AID - ijerph-18-07178 [pii] AID - 10.3390/ijerph18137178 [doi] PST - epublish SO - Int J Environ Res Public Health. 2021 Jul 5;18(13):7178. doi: 10.3390/ijerph18137178.